Previous Article | Next Article ![]()
Infection and Immunity, March 2000, p. 1480-1484, Vol. 68, No. 3
Institute for Immunology and Radiobiology,
Purkyn
Received 3 September 1999/Returned for modification 26 October
1999/Accepted 10 December 1999
The implication of the Bcg locus in the control of
natural resistance to infection with a live vaccine strain (LVS) of the intracellular pathogen Francisella tularensis was studied.
Analysis of phenotypic expression of natural resistance and
susceptibility was performed using mouse strains congenic at the
Bcg locus. Comparison of the kinetics of bacterial
colonization of spleen showed that B10.A.Bcg(r) mice were
extremely susceptible during early phases of primary sublethal
infection, while their congenic C57BL/10N [Bcg(s)]
counterparts could be classified as resistant to F. tularensis LVS infection according to the 2-log-lower bacterial
CFU within the tissue as long as 5 days after infection. Different
phenotypes of Bcg congenic mice were associated with
differential expression of the cytokines tumor necrosis factor alpha,
interleukin-10, and gamma interferon and production of reactive oxygen
intermediates. These results strongly suggest that the Bcg
locus, which is close or identical to the Nramp1 gene,
controls natural resistance to infection by F. tularensis
and that its effect is the opposite of that observed for other
Bcg-controlled pathogens.
The establishment of protective
immunity to intracellular bacterial pathogens involves an early innate
immunity followed by an acquired immune response (12).
Resistance or susceptibility to infection results from the interplay
between genetic variability in the host response and the pathogen's
virulence. Genetic control of natural resistance is phenotypically
expressed by the ability of a host to restrict the rate of early
intracellular growth of a pathogen before development of an effective
T-cell-mediated immunity (13, 33). One of the best-studied
susceptibility genes is Nramp1. It maps to the
30-centimorgan (cM) locus, formerly named bcg, located on
chromosome 1 in mice (34). Gene knockout and transgenesis
provided final verification that the Nramp1 gene is
implicated in resistance to taxonomically and antigenically unrelated
microorganisms like Mycobacterium bovis, Salmonella typhimurium, and Leishmania donovani (19,
35). In mice, Nramp1 is expressed by macrophages in
two allelic forms, resistant (r) and susceptible
(s); the latter has the 169Gly-to-169Asp substitution, which
confers susceptibility to infection (28). Expression of the
Bcg(r) [Nramp1(r)] allele has many in vitro
pleiotropic effects associated with priming or activation of
macrophages in response to interferon gamma (IFN- Francisella tularensis is a gram-negative, facultatively
intracellular bacterium and the etiological agent of tularemia, a disease of a variety of animal hosts (30). An attenuated
vaccine strain (LVS) of F. tularensis, developed as a human
vaccine, is more or less virulent for various strains of mice.
Experimental murine tularemia is thus considered an excellent model of
human disease, including mechanisms of antibacterial resistance. As in
other intracellular bacteria, protein antigens of F. tularensis LVS induce T-cell-mediated immunity, which contributes
significantly to host protection and is responsible for ultimate
clearance of the bacterium (32). Cytokines such as IFN- Studies on the genetic basis of resistance to murine tularemia have
shown that the phenotype of resistance is inherited in a dominant
manner and the mode of inheritance is complex, involving multiple
genetic loci (3). Comparing an F. tularensis
LVS-susceptible C3H [Lps(n/d) Bcg(r)] murine model with
C57BL/10N [Lps(n) Bcg(s)] mice, which are noticeably
resistant to tularemia, we have previously shown that early onset of
TNF- Mice.
Specific-pathogen-free 6- to 8-week-old female
C57BL/10N [Bcg(s)] mice were obtained from Charles River
Deutschland (Sulzfeld, Germany), and the congenic
B10.A.Bcg(r) strain (11) was obtained initially
from E. Skamene (McGill University, Montreal, Canada) and bred and
maintained in our laboratories in conventional facilities. This
congenic strain was constructed by the backcross NX system using
resistance to Mycobacterium bovis BCG Montreal as a
selective agent. B10.A.Bcg(r) mice are identical with the
C57BL/10N [Bcg(s)] strain except for the 30-cM segment of
chromosome 1 that contains the Bcg locus, in which the
Nramp1 gene, associated with resistance to M. bovis BCG, is located.
Experimental infection in mice.
The infectious inoculum of
F. tularensis LVS (ATCC 29684; American Type Culture
Collection, Manassas, Va.) was prepared as described previously
(27). Bcg(r) or Bcg(s) mice (three to
six per group) were inoculated subcutaneously (s.c.) in the left hind leg with 0.1 ml of physiological saline containing 102 CFU
of F. tularensis LVS. The degree of infection was assessed by determining the number of CFU in the spleen at predetermined time
intervals. Briefly, the homogenate of the spleen of each individual
mouse was prepared in sterile physiological solution by sieving,
further serially diluted in the same buffer, and plated in triplicate
samples onto Müeller-Hinton solid medium. The number of F. tularensis LVS CFU was determined after a 72-h incubation of the
plates at 37°C.
Cell cultures.
Spleens from mice sacrificed at predetermined
time intervals were removed, and cell suspensions were prepared in RPMI
1640 culture medium (SEBAK Biologische Forschungs-GmbH, Aidenbach, Germany) supplemented with 50 µg of glutamine (USOL, Prague, Czech Republic)/ml, 0.25 mg of gentamicin (Sigma, St. Louis, Mo.)/ml, and 5%
fetal calf serum (FCS; Bioveta, Ivanovice, Czech Republic). Cells were
then dispensed in duplicate into 24-well flat-bottom tissue culture
plates at 2 × 106 cells per well in 1.0 ml of culture
medium and were incubated at 37°C under 5% CO2. Cell
culture supernatants were collected at 24 h for IFN-
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Influence of the Bcg Locus on Natural Resistance to
Primary Infection with the Facultative Intracellular Bacterium
Francisella tularensis in Mice
ová,1,*
írová,3 and
Macela1
Military Medical Academy, 500 01 Hradec
Králové,1 Department of
Pediatrics, Faculty of Medicine, Palacky University and Faculty
Hospital, 775 15 Olomouc,2 and Institute
of Microbiology, Academy of Science of the Czech Republic, 142 20 Prague,3 Czech Republic
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
),
lipopolysaccharide (LPS), or other bacterial components. It is probable
that these observations can be relevant to resistance and
susceptibility to in vivo infections also (5, 6). It has
been shown that the Nramp1 protein is a member of an ancient family of
proteins with a typical structural organization of ion transporters and
channels (8). These findings, together with the
identification of bacterial homologues of cation transporters, suggest
a model in which competition for divalent metal cations between host
and parasite may be related to host resistance or susceptibility to the
pathogen (1, 4).
and tumor necrosis factor alpha (TNF-
) are key regulators, since
neutralization of these cytokines in vivo increased the severity of the
Francisella infection while systemic administration of these
cytokines reduced it (16). The cooperation of IFN-
and
TNF-
in the induction of the synthesis of NO and the possible
regulation of iron homeostasis and pH appear to be important in
limiting the survival of Francisella within macrophages
(17). The mechanisms of innate immunity that follow after
internalization of the bacterium into macrophages deserve further
study, as they may have a strong impact on the development of specific
immunity and the protection of the host.
production and/or production of reactive oxygen intermediates
(ROI) contributes significantly to resistance against tularemia
(23, 27). To ascertain whether the Bcg locus, one
of the possible candidates in these different genetic backgrounds,
might be implicated in the control of natural resistance to tularemia,
we performed an analysis of phenotypic expression of early resistance
and susceptibility using mouse strains derived from C57BL/10 mice and
congenic at the Bcg locus. Comparison of the kinetics of
bacterial colonization of the spleen showed that
B10.A.Bcg(r) mice, compared to their F. tularensis LVS-resistant Bcg(s) counterparts, were
extremely susceptible during the early phases of primary sublethal
infection. Different phenotypes of Bcg congenic mice were
associated with differential expression of the cytokines TNF-
,
interleukin-10 (IL-10), and IFN-
and differential production of ROI.
These results strongly suggest that the Bcg locus, which is
close or identical to the Nramp1 gene, controls natural
resistance to infection by F. tularensis and that its effect
is the opposite of that observed for other Bcg-controlled pathogens.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
detection
and were stored at
80°C.
and IL-10 detection and were stored
at
80°C. For measurement of ROI and nitrite, PEC were dispensed in
quadruplicate into 96-well culture plates at an approximate density of
5 × 106 cells/ml in 0.2-ml aliquots per well, and
nonadherent cells were removed by washing with physiological buffered
saline after a 2-h incubation at 37°C under 5% CO2. The
numbers of adherent cells (macrophages) were the same in both
Bcg(r) and Bcg(s) PEC.
Cytokine assays.
Cytokines in ex vivo spleen or PEC
cell-free culture supernatants were detected using Quantikine M kits
(R&D Systems Europe, Oxon, United Kingdom) for the quantitative
determination of mouse IFN-
, TNF-
, and IL-10. The assay was
performed according to the manufacturer's instructions. The assay
employs the quantitative sandwich enzyme immunoassay technique.
Determination of ROI levels. ROI levels were assessed by a colorimetric assay using reduction of INT (iodophenyl-nitrophenyl-phenyltetrazolium chloride; Sigma) mediated by electron-transporting pathways of peritoneal cells (24). Adherent peritoneal cells at an approximate density of 5 × 105 cells per well in 96-well plates were incubated with 40 µl of 0.1% INT in buffered physiological saline at 37°C for 30 min. Then the plates were centrifuged, the supernatants were aspirated from the wells, and 150 µl of dimethyl sulfoxide was added to extract reduced formazan. The A450 per well was determined using a Dynex MRX (Dynatech Laboratories).
NO assay. NO in 24-h-conditioned macrophage culture supernatants was measured as amounts of nitrite, a stable product of NO decay, using Griess reagent (20).
Analysis of data. Statistical analysis was performed using unpaired two-tailed Student's t tests to compare Bcg congenic strains of mice at each time point, and the 95% confidence limit was assumed to establish the level of significance.
| |
RESULTS |
|---|
|
|
|---|
Bacterial load in spleens of congenic Bcg(s) and
Bcg(r) mice.
To examine whether natural resistance or
susceptibility to infection with F. tularensis LVS is
controlled by the Bcg locus, we compared C57BL/10N
[Bcg(s)] mice with their congenic counterparts B10.A.Bcg(r), which differ in the chromosome segment
containing the studied locus. Mice of each strain were infected s.c.
with a sublethal dose of F. tularensis LVS (102
CFU/mouse), and the number of bacteria in the spleen was
determined at different times after infection. As shown in Fig.
1, the number of bacteria increased
rapidly in the first 3 days and reached a maximum 5 days after
infection. After this time, the infection underwent resolution and was
under the detection limit of the CFU assay in the spleens of
C57BL/10N [Bcg(s)] and B10.A.Bcg(r) mice
for 14 and 21 days, respectively. Nevertheless, in the course of the
early period, B10.A.Bcg(r) mice showed significantly higher bacterial loads in the spleen than did C57BL/10N [Bcg(s)]
mice. The coefficient of increase, c, expressed as a ratio
of the mean number of bacterial CFU in the spleen at 5 days after
infection and the CFU injected initially (log10
CFU5d/log10 CFU0d), yields a value of 4.5 for
B10.A.Bcg(r) mice and 2.6 for C57BL/10N
[Bcg(s)] mice. The former group is classified as
susceptible, while the latter is classified as resistant according to
the above criteria. Based on our results (data not shown) as well as
other observations (9, 14) demonstrating for various inbred
mouse strains and the routes of F. tularensis LVS infection
that bacterial growth curves in the livers and spleens are practically
congruent, we have measured the bacterial burdens in spleens only and
consider the values sufficient and a reliable measure of the ability of a host to control bacterial growth.
|
Cytokine responses in infected Bcg congenic mice.
Since the cytokines IFN-
and TNF-
are required for early
nonspecific-phase immunity as well as for T-cell-mediated immunity in
mice infected with F. tularensis LVS (15, 18), we
addressed the question whether upon infection of congenic
Bcg(s) and Bcg(r) mice, these cytokines are
produced at different levels. Besides IFN-
and TNF-
, mentioned
above, we also measured the level of IL-10, the cytokine that exerts
activity contrasting to that of TNF-
. Bcg(s) and
Bcg(r) mice were infected with equal and relatively low
initial bacterial doses that allowed analysis of phenotypic expression
of resistance and susceptibility during the course of infection. As
depicted in Fig. 2a, significantly
higher levels of TNF-
were found in the supernatants of
C57BL/10N [Bcg(s)] PEC than in the supernatants of
B10.A.Bcg(r) PEC from day 3 after in vivo infection.
Analysis of IL-10 showed (Fig. 2b) a significant difference in
endogenous levels between congenic Bcg(s) and
Bcg(r) mice, which may represent one of many pleiotropic
effects of the Bcg locus (5). The initially high
endogenous IL-10 levels decreased in supernatants of C57BL/10N
[Bcg(s)] PEC, and IL-10 reached minimal levels on day 5 after infection (significance level,
P < 0.05). In contrast, the low endogenous levels of
IL-10 observed in B10.A.Bcg(r) supernatants were increased
2.5-fold (significance level, P < 0.05) during
the course of infection. IFN-
responses to infection were measured
in supernatants of spleen cells, and the results are shown in Fig. 2c.
While production occurs 5 to 7 days after infection in both congenic
mouse strains, B10.A.Bcg(r) spleen cells showed
significantly higher (up to threefold-higher) IFN-
levels than the
spleen cells of C57BL/10N [Bcg(s)] mice.
|
Relationship of Bcg resistant or susceptible genotype
of macrophages with the production of ROI and nitrite.
Table
1 shows the kinetics of ex vivo
production of ROI and nitrite by congenic macrophages. While
B10.A.Bcg(r) macrophages constitutively produced a small
amount of nitrite, no significant differences between congenic
macrophages in the amount of nitrite induced by infection were
observed. In contrast, oxidative metabolism during the course of LVS
infection, revealed by ROI production mediated by macrophage electron
transport pathways, generated significant differences between the
two mouse strains. An early increase, more pronounced in
F. tularensis LVS-resistant C57BL/10N [Bcg(s)] macrophages on days 3 and 5, was followed by
suppression on day 7. On the contrary, at this later time,
B10.A.Bcg(r) macrophages produced high levels of ROI.
|
| |
DISCUSSION |
|---|
|
|
|---|
The genetic basis of host response to infection provides a major
regulatory interface that influences the ability to restrict and
eliminate pathogens. Variation in the resistance or susceptibility of
mice to infection with F. tularensis has been recognized and shown to be a multifactorial trait (3). To observe the
possible contribution of the Bcg locus, we performed a study
of phenotypic expression of natural resistance and susceptibility using
mice congenic at this single gene interval. Our results have
demonstrated that B10.A.Bcg(r) mice, carrying the resistant
allele of the Bcg locus and known to express higher levels
of growth-inhibiting activity toward mycobacteria than C57BL/10N
[Bcg(s)] mice (21), are susceptible to primary
infection with F. tularensis LVS, as shown by a significant
early increase in bacterial CFU within the tissue. In contrast, their
congenic C57BL/10N [Bcg(s)] counterparts could be
classified as resistant to infection. We have utilized a model with low
doses of bacteria in order to investigate the capacity of genetic
systems of natural resistance to infection, which might be hidden when
a high antigenic load is applied. The fact that the size of the
infective inoculum is critical and must be considered in determining
genetic resistance or susceptibility has been noted in BCG infection.
When high doses (>104 CFU) were used, an inverse
relationship between the inoculum size and the rate of BCG
multiplication could be observed. These results were interpreted to be
the effect of specific cell-mediated immunity, which develops with a
short latency period and is responsible for the control of bacterial
counts in mice infected with large inocula (13). The data
presented, taken together with our previous results (23,
27; H. Ková
ová, unpublished data) obtained with other strains of mice sharing the Bcg alleles, suggest
that the Bcg locus exerts an influence on the early phase of
primary F. tularensis infection.
It is well established that the effector cell responsible for the
phenotypic expression of the Bcg locus in mice is the
macrophage (34). Studies on the mechanisms of host defense
against F. tularensis point to the macrophage as the
effector cell ultimately responsible for resistance to tularemia
(15), although the relevant contribution of other cells
cannot be neglected (9, 10). The mechanism by which
C57BL/10N [Bcg(s)] macrophages exert enhanced cytocidal or
cytostatic activity toward F. tularensis LVS is not
clear. Since many pleiotropic effects of the Bcg locus
(6) are likely to be mediated by affecting the
redox-sensitive cellular signaling pathways (7, 26), we
expect that one of the possible mechanisms by which the Bcg
locus determines relative resistance or susceptibility to infection is
differential cytokine expression. C57BL/10N [Bcg(s)] PEC
appear to be superior to B10.A.Bcg(r) PEC in the production of TNF-
and ROI early in the response to infection. This is
consistent with the findings of our previous studies (23)
demonstrating a possible association between resistance to
infection and TNF-
production coupled with cellular redox
regulation. While the up-regulation of the proinflammatory
cytokine TNF-
in Bcg(s) mice is accompanied by a decrease
in levels of the anti-inflammatory cytokine IL-10, the kinetics of
IL-10 in Bcg(r) mice is, in contrast, increased. Adverse
changes noted in the expression of TNF-
and IL-10 under the
influence of the Bcg locus are of crucial importance at the initial stages of inflammation. Our current experiments indicate (data
not shown) that observed ex vivo differences in early resistance to infection and differential expression of TNF-
levels can be well reproduced in vitro using Bcg congenic macrophage lines.
As already mentioned, B10.A.Bcg(r) mice, but not their
Bcg(s) counterparts, are capable of reaching high levels of
IFN-
and ROI 5 and 7 days after infection, respectively. This points
towards possible interaction between macrophages and other cells, such as T cells or NK cells, which represent major producers of IFN-
. Regarding the time course of infection, this effect coincides with the
time when the initial events of cell-mediated acquired immunity occur
(2, 25). It is likely that B10.A.Bcg(r) mice, which are naturally susceptible to F. tularensis LVS,
preserve the mechanism to polarize cytokine response in favor of
Th1 cells. This suggestion is supported by the previously described
observation that enhanced antigen processing and presentation in
macrophages carrying the Bcg(r)
[Nramp1(r)] allele are functionally associated with an
enhanced Th1 response (31).
Although we are not able to distinguish whether the Nramp1 gene or another gene located in Bcg locus is involved in the control of the replication of F. tularensis LVS, recent results on the mechanism of the Nramp gene family in the control of host natural resistance indicate that the expression of the Nramp1 gene might be related to the innate phase of response to F. tularensis LVS infection. It has been demonstrated that the phagocyte-specific Nramp1 protein is localized in late-endosomal and lysosomal compartments (29) and that it regulates the intraphagosomal replication of live mycobacteria by altering phagosomal pH (22). Nramp1(r)-expressing macrophages display considerably enhanced acidification compared to the macrophages carrying the susceptible allele of the gene. This effect appeared to be associated with an enhanced ability of mycobacterial phagosomes to fuse with vacuolar-type ATPase-containing late endosomes and/or lysosomes. Our observation indicates that expression of the mutant allele Bcg(s) of the Bcg locus (the Nramp1 gene) could be hostile to F. tularensis LVS, while the resistant allele could mediate a permissive environment after internalization of the pathogen. This finding is in contrast to those for other microorganisms such as M. bovis, S. typhimurium, and L. donovani (13, 19, 35). Furthermore, it has been demonstrated, using agents that block acidification, that F. tularensis LVS does require an acidic environment for intracellular growth. This acidification can be linked to the availability of nutrient iron (17).
The nature of anti-Francisella natural resistance and susceptibility operating under the influence of the Bcg locus (the Nramp1 gene) at the level of phagosomal-phagolysosomal pH regulation and iron flux is currently under scrutiny.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by the Grant Agency of the Czech Republic (grant 310/99/1185 to H.K.), the Ministry of Defense (grant MO66020398130 to H.K.), and the Ministry of Education, Youth and Sports (grant VZ J14/98 151100001 to M.H.).
We are grateful to E. Skamene of McGill University for providing us with B10.A.Bcg(r) mice. We thank K. L. Elkins of the Center for Biologics Evaluation and Research, Rockville, Md., and D. G. Russell of Washington University, St. Louis, Mo., for critical reading of the manuscript and helpful discussion. We are indebted to I. Lefkovits of the Basel Institute for Immunology, Basel, Switzerland, for editorial help.
| |
FOOTNOTES |
|---|
*
Corresponding author. Mailing address: Institute for
Immunology and Radiobiology, Trebe
ská Str. 1575, 500 01 Hradec Králové, Czech Republic. Phone: (420 49) 5210833. Fax: (420 49) 5513018. E-mail: kovarova{at}pmfhk.cz.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Agranoff, D., and S. Krishna. 1998. Metal ion homeostasis and intracellular parasitism. Mol. Microbiol. 28:403-412[CrossRef][Medline]. |
| 2. | Anthony, L. S. D., and P. A. L. Kongshavn. 1987. Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance. Microb. Pathog. 2:3-14[CrossRef][Medline]. |
| 3. |
Anthony, L. S. D.,
E. Skamene, and P. A. L. Kongshavn.
1988.
Influence of genetic background on host resistance to experimental murine tularemia.
Infect. Immun.
56:2089-2093 |
| 4. | Atkinson, P. G., and C. H. Barton. 1999. High level expression of Nramp1G169 in RAW264.7 cell transfectants: analysis of intracellular iron transport. Immunology 96:656-662[CrossRef][Medline]. |
| 5. | Blackwell, J. M., T. I. Roach, P. G. Atkinson, J. W. Ajioka, C. H. Barton, and M. A. Shaw. 1991. Genetic regulation of macrophage priming/activation: the Lsh gene story. Immunol. Lett. 30:241-248[CrossRef][Medline]. |
| 6. | Blackwell, J. M., C. H. Barton, J. K. White, T. L. Roach, M. A. Shaw, S. H. Whitehead, B. A. Mock, S. Searle, H. Williams, and A. M. Baker. 1994. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Immunol. Lett. 43:99-107[CrossRef][Medline]. |
| 7. | Blackwell, J. M., and S. Searle. 1999. Genetic regulation of macrophage activation: understanding the function of Nramp1 (=Ity/Lsh/Bcg). Immunol. Lett. 65:73-80[CrossRef][Medline]. |
| 8. |
Cellier, M.,
G. Prive,
A. Belouchi,
T. Kwan,
V. Rodrigues,
W. Chia, and P. Gros.
1995.
Nramp defines a family of membrane proteins.
Proc. Natl. Acad. Sci. USA
92:10089-10093 |
| 9. |
Conlan, J. W.,
A. Sjöstedt, and R. J. North.
1994.
CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice.
Infect. Immun.
62:5603-5607 |
| 10. | Culkin, S. J., T. Rheinehart-Jones, and K. L. Elkins. 1997. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol. 158:3272-3284. |
| 11. | Denis, M., A. Forget, M. Pelletier, and E. Skamene. 1988. Pleiotropic effects of the Bcg gene. I. Antigen presentation in genetically susceptible and resistant congenic mouse strains. J. Immunol. 140:2395-2400[Abstract]. |
| 12. | Fearon, D. T., and R. M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-54[Abstract]. |
| 13. |
Forget, A.,
E. Skamene,
P. Gros,
A. C. Miailhe, and R. Turcotte.
1981.
Differences in response among inbred mouse strains to infection with small doses of Mycobacterium bovis BCG.
Infect. Immun.
32:42-47 |
| 14. |
Fortier, A. H.,
M. V. Slater,
R. Ziemba,
M. S. Meltzer, and C. A. Nacy.
1991.
Live vaccine strain of Francisella tularensis: infection and immunity in mice.
Infect. Immun.
59:2922-2928 |
| 15. |
Fortier, A. H.,
T. Polsinelli,
S. J. Green, and C. A. Nacy.
1992.
Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules.
Infect. Immun.
60:817-825 |
| 16. | Fortier, A. H., S. J. Green, T. Polsinelli, T. R. Jones, R. M. Crawford, D. A. Lieby, K. L. Elkins, M. S. Meltzer, and C. A. Nacy. 1994. Life and death of an intracellular pathogen: Francisella tularensis and the macrophage, p. 349-363. In B. S. Zwilling, and T. K. Eisenstein (ed.), Macrophage-pathogen interactions. Marcel Dekker Inc., New York, N.Y. |
| 17. | Fortier, A. H., D. A. Leiby, R. B. Narayan, E. Asafoadjei, R. M. Crawford, C. A. Nacy, and M. S. Meltzer. 1995. Growth of Francisella tularensis LVS in macrophages: the acidic intracellular compartment provides essential iron required for growth. Infect. Immun. 63:1478-1483[Abstract]. |
| 18. | Golovliov, I., G. Sandström, M. Ericsson, A. Sjöstedt, and A. Tärnvik. 1995. Cytokine expression in the liver during the early phase of murine tularemia. Infect. Immun. 63:534-538[Abstract]. |
| 19. | Govoni, G., S. Vidal, S. Gauthier, E. Skamene, D. Malo, and P. Gros. 1996. The Bcg/Ity/Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1Gly169 allele. Infect. Immun. 64:2923-2929[Abstract]. |
| 20. | Green, L. C., D. A. Wagner, J. Glogowski, P. I. Skipper, J. S. Whisnok, and S. R. Tannenbaum. 1989. Analysis of nitrite, nitrate and [15]N nitrite in biological fluids. Anal. Biochem. 126:131-138. |
| 21. | Gros, P., E. Skamene, and A. Forget. 1981. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J. Immunol. 127:2417-2421[Abstract]. |
| 22. |
Hackam, D. J.,
O. D. Rotstein,
W. Zhang,
S. Gruenheid,
P. Gros, and S. Grinstein.
1998.
Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification.
J. Exp. Med.
188:351-364 |
| 23. |
Hernychová, L.,
H. Ková ová,
A. Macela,
M. Kro a,
Z. Kro ová, and J. Stulík.
1997.
Early consequences of macrophage-Francisella tularensis interaction under the influence of different genetic background in mice.
Immunol. Lett.
57:75-81[CrossRef][Medline].
|
| 24. |
Ková ová, H.,
A. Macela,
J. Stulík,
P. Propper, and M. Ledvina.
1987.
The role of phagocytes and specific antibodies in gamma irradiated mice infected by intracellular pathogen.
Stud. Biophys.
121:173-182.
|
| 25. |
Ková ová, H.,
A. Macela, and J. Stulik.
1992.
Macrophage activating factors produced in the course of murine tularemia: effect on multiplication of microbes.
Arch. Immunol. Therap. Exp.
40:183-190.
|
| 26. |
Ková ová, H.,
D. Radzioch,
M. Hajdúch,
M. írová,
V. Bláha,
A. Macela, and J. Stulík.
1998.
Natural resistance to intracellular parasites: a study by two-dimensional gel electrophoresis coupled with multivariate analysis.
Electrophoresis
19:1325-1331[CrossRef][Medline].
|
| 27. |
Macela, A.,
J. Stulík,
L. Hernychová,
M. Kro a,
Z. Kro ová, and H. Ková ová.
1996.
The immune response against Francisella tularensis live vaccine strain in Lpsn and Lpsd mice.
FEMS Immunol. Med. Microbiol.
13:235-239[CrossRef][Medline].
|
| 28. | Malo, D., K. Vogan, S. Vidal, J. Hu, M. Cellier, E. Schurr, A. Fuks, N. Bumstead, K. Morgan, and P. Gros. 1994. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 23:51-61[CrossRef][Medline]. |
| 29. | Searle, S., N. A. Bright, T. I. Roach, P. G. Atkinson, C. H. Barton, R. H. Meloen, and J. M. Blackwell. 1998. Localisation of Nramp1 in macrophages: modulation with activation and infection. J. Cell Sci. 111:2855-2866[Abstract]. |
| 30. | Sjöstedt, A., A. Tärnvik, and G. Sandström. 1996. Francisella tularensis: host-parasite interaction. FEMS Immunol. Med. Microbiol. 13:181-184[Medline]. |
| 31. |
Soo, S. S.,
B. Villarreal-Ramos,
C. M. Ahjam Khan,
C. E. Hormaeche, and J. M. Blackwell.
1998.
Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge.
Infect. Immun.
66:1910-1917 |
| 32. | Tärnvik, A., M. Ericsson, I. Golovliov, G. Sandström, and A. Sjöstedt. 1996. Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. FEMS Immunol. Med. Microbiol. 13:221-225[CrossRef][Medline]. |
| 33. | Unanue, E. R. 1997. Studies in listeriosis show the strong symbiosis between the innate cellular system and the T-cell response. Immunol. Rev. 158:11-15[CrossRef][Medline]. |
| 34. | Vidal, S. M., D. Malo, K. Vogan, E. Skamene, and P. Gros. 1993. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 73:469-485[CrossRef][Medline]. |
| 35. |
Vidal, S.,
M. L. Tremblay,
G. Govoni,
S. Gauthier,
G. Sebastini,
D. Malo,
E. Skamene,
M. Olivier,
S. Jothy, and P. Gros.
1995.
The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene.
J. Exp. Med.
182:655-666 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»